71 related articles for article (PubMed ID: 28718065)
1. Structure-function relationships of protein-lipopeptide complexes and influence on immunogenicity.
Wijayadikusumah AR; Sullivan LC; Jackson DC; Chua BY
Amino Acids; 2017 Oct; 49(10):1691-1704. PubMed ID: 28718065
[TBL] [Abstract][Full Text] [Related]
2. Geometry of a TLR2-Agonist-Based Adjuvant Can Affect the Resulting Antigen-Specific Immune Response.
Wijayadikusumah AR; Zeng W; McQuilten HA; Wong CY; Jackson DC; Chua BY
Mol Pharm; 2019 May; 16(5):2037-2047. PubMed ID: 30924661
[TBL] [Abstract][Full Text] [Related]
3. PEGylation of a TLR2-agonist-based vaccine delivery system improves antigen trafficking and the magnitude of ensuing antibody and CD8
Sekiya T; Yamagishi J; Gray JHV; Whitney PG; Martinelli A; Zeng W; Wong CY; Sugimoto C; Jackson DC; Chua BY
Biomaterials; 2017 Aug; 137():61-72. PubMed ID: 28544973
[TBL] [Abstract][Full Text] [Related]
4. The use of a TLR2 agonist-based adjuvant for enhancing effector and memory CD8 T-cell responses.
Chua BY; Olson MR; Bedoui S; Sekiya T; Wong CY; Turner SJ; Jackson DC
Immunol Cell Biol; 2014 Apr; 92(4):377-83. PubMed ID: 24394993
[TBL] [Abstract][Full Text] [Related]
5. Soluble proteins induce strong CD8+ T cell and antibody responses through electrostatic association with simple cationic or anionic lipopeptides that target TLR2.
Chua BY; Pejoski D; Turner SJ; Zeng W; Jackson DC
J Immunol; 2011 Aug; 187(4):1692-701. PubMed ID: 21742967
[TBL] [Abstract][Full Text] [Related]
6. A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population.
Wu CC; Liu SJ; Chen HW; Shen KY; Leng CH
Oncotarget; 2016 May; 7(21):30804-19. PubMed ID: 27127171
[TBL] [Abstract][Full Text] [Related]
7. A surfactin cyclopeptide of WH1fungin used as a novel adjuvant for intramuscular and subcutaneous immunization in mice.
Gao Z; Wang S; Qi G; Pan H; Zhang L; Zhou X; Liu J; Zhao X; Wu J
Peptides; 2012 Nov; 38(1):163-71. PubMed ID: 22982610
[TBL] [Abstract][Full Text] [Related]
8. OVA-bound nanoparticles induce OVA-specific IgG1, IgG2a, and IgG2b responses with low IgE synthesis.
Yanase N; Toyota H; Hata K; Yagyu S; Seki T; Harada M; Kato Y; Mizuguchi J
Vaccine; 2014 Oct; 32(45):5918-24. PubMed ID: 25211769
[TBL] [Abstract][Full Text] [Related]
9. A new TLR2 agonist promotes cross-presentation by mouse and human antigen presenting cells.
Santone M; Aprea S; Wu TY; Cooke MP; Mbow ML; Valiante NM; Rush JS; Dougan S; Avalos A; Ploegh H; De Gregorio E; Buonsanti C; D'Oro U
Hum Vaccin Immunother; 2015; 11(8):2038-50. PubMed ID: 26024409
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant effects of salidroside from Rhodiola rosea L. on the immune responses to ovalbumin in mice.
Guan S; He J; Guo W; Wei J; Lu J; Deng X
Immunopharmacol Immunotoxicol; 2011 Dec; 33(4):738-43. PubMed ID: 21711135
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route.
Lombardi V; Van Overtvelt L; Horiot S; Moussu H; Chabre H; Louise A; Balazuc AM; Mascarell L; Moingeon P
Clin Exp Allergy; 2008 Nov; 38(11):1819-29. PubMed ID: 18644025
[TBL] [Abstract][Full Text] [Related]
12. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
[TBL] [Abstract][Full Text] [Related]
13. CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice.
Maletto B; Rópolo A; Morón V; Pistoresi-Palencia MC
J Leukoc Biol; 2002 Sep; 72(3):447-54. PubMed ID: 12223511
[TBL] [Abstract][Full Text] [Related]
14. Immunological adjuvant effect of Boswellia serrata (BOS 2000) on specific antibody and cellular response to ovalbumin in mice.
Gupta A; Khajuria A; Singh J; Singh S; Suri KA; Qazi GN
Int Immunopharmacol; 2011 Aug; 11(8):968-75. PubMed ID: 21371582
[TBL] [Abstract][Full Text] [Related]
15. Immune effector cells induced by complete Freund's adjuvant exert an inhibitory effect on antigen-specific type 2 T helper responses.
Chuang YH; Chiang BL; Chou CC; Hsieh KH
Clin Exp Allergy; 1997 Mar; 27(3):315-24. PubMed ID: 9088658
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor-2 agonist-allergen coupling efficiently redirects Th2 cell responses and inhibits allergic airway eosinophilia.
Krishnaswamy JK; Jirmo AC; Baru AM; Ebensen T; Guzmán CA; Sparwasser T; Behrens GM
Am J Respir Cell Mol Biol; 2012 Dec; 47(6):852-63. PubMed ID: 22962064
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.
Huleatt JW; Jacobs AR; Tang J; Desai P; Kopp EB; Huang Y; Song L; Nakaar V; Powell TJ
Vaccine; 2007 Jan; 25(4):763-75. PubMed ID: 16968658
[TBL] [Abstract][Full Text] [Related]
18. Study of the adjuvanticity of lysine lipopeptides; carbamate analogs elicit strong Th1 and Th2 response to ovalbumin in mice.
Ismail T; Shafi S; Gupta A; Khajuria A; Sidiq T; Reddy DM; Alam MS; Qazi GN; Kumar HM
Int Immunopharmacol; 2011 Nov; 11(11):1855-63. PubMed ID: 21884823
[TBL] [Abstract][Full Text] [Related]
19. Roles of CD4+ and CD8+ T cells in adjuvant activity of diesel exhaust particles in mice.
Fujimaki H; Ui N; Ushio H; Nohara K; Endo T
Int Arch Allergy Immunol; 2001 Apr; 124(4):485-96. PubMed ID: 11340332
[TBL] [Abstract][Full Text] [Related]
20. The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.
Schmidt ST; Khadke S; Korsholm KS; Perrie Y; Rades T; Andersen P; Foged C; Christensen D
J Control Release; 2016 Oct; 239():107-17. PubMed ID: 27574990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
